A Door Opener for Future Research: Agonist-induced β3-adrenoceptor Desensitization in HEK Cells but Not CHO Cells
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Echeverria E, Cabrera M, Burghi V, Sosa M, Ripoll S, Yaneff A Front Pharmacol. 2020; 11:113.
PMID: 32153413 PMC: 7047201. DOI: 10.3389/fphar.2020.00113.
Michel M Naunyn Schmiedebergs Arch Pharmacol. 2013; 387(3):215-24.
PMID: 24213882 DOI: 10.1007/s00210-013-0936-2.
References
1.
Scott J, Dessauer C, Tasken K
. Creating order from chaos: cellular regulation by kinase anchoring. Annu Rev Pharmacol Toxicol. 2012; 53:187-210.
PMC: 3540170.
DOI: 10.1146/annurev-pharmtox-011112-140204.
View
2.
Emorine L, Feve B, Pairault J, Marullo S, DELAVIER-KLUTCHKO C, Strosberg D
. Structural basis for functional diversity of beta 1-, beta 2- and beta 3-adrenergic receptors. Biochem Pharmacol. 1991; 41(6-7):853-9.
DOI: 10.1016/0006-2952(91)90188-b.
View
3.
Reiter E, Ahn S, Shukla A, Lefkowitz R
. Molecular mechanism of β-arrestin-biased agonism at seven-transmembrane receptors. Annu Rev Pharmacol Toxicol. 2011; 52:179-97.
PMC: 3628752.
DOI: 10.1146/annurev.pharmtox.010909.105800.
View
4.
Kinast L, von der Ohe J, Burhenne H, Seifert R
. Impairment of adenylyl cyclase 2 function and expression in hypoxanthine phosphoribosyltransferase-deficient rat B103 neuroblastoma cells as model for Lesch-Nyhan disease: BODIPY-forskolin as pharmacological tool. Naunyn Schmiedebergs Arch Pharmacol. 2012; 385(7):671-83.
DOI: 10.1007/s00210-012-0759-6.
View
5.
Tchivileva I, Tan K, Gambarian M, Nackley A, Medvedev A, Romanov S
. Signaling pathways mediating beta3-adrenergic receptor-induced production of interleukin-6 in adipocytes. Mol Immunol. 2009; 46(11-12):2256-66.
PMC: 2740928.
DOI: 10.1016/j.molimm.2009.04.008.
View